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Trial regiAbstract: Chronic low back pain (CLBP) is a major cause of global disability and improving manage-
ment is essential. Acceptance and commitment therapy (ACT) is a promising treatment for chronic
pain but has not been modified for physical therapy. This randomized controlled trial (RCT) compared
physical therapy informed by ACT (PACT) against standard care physical therapy for patients with
CLBP. Patients with CLBP (duration ≥12 weeks, mean 3 years) were recruited from physical therapy
clinics in 4 UK public hospitals. The Roland-Morris Disability Questionnaire (RMDQ) at 3 months’ post-
randomization was the primary outcome. Two hundred forty-eight participants (59% female, mean
age = 48) were recruited and 219 (88.3%) completed measures at 3 and/or 12 months’ follow-up. At
3 months, PACT participants reported better outcomes for disability (RMDQ mean difference = 1.07,
p = .037, 95% CI =2.08 to .07, d = .2), Patient Specific Functioning (p = .008), SF12 physical health
(p = .032), and treatment credibility (p < .001). At 12 months’ follow-up, there were no significant dif-
ferences between groups. PACT was acceptable to patients and clinicians and feasible to deliver.
Physical therapists incorporated psychological principles successfully and treatment was delivered
with high (≥80%) fidelity. Our results may inform the management of CLBP, with potential benefits
for patients, health care providers, and society.
Perspective: Psychologically informed physical therapy has great potential but there are chal-
lenges in implementation. The training and support included in the PACT trial enabled the interven-
tion to be delivered as planned. This successfully reduced disability in the short but not long term.
Findings could inform physical therapists’ treatment of CLBP.
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RCT of Physical Therapy Informed by ACT for CLBPL
owback pain is the leading cause of global disabil-
ity1-3 and urgently requires better management.2
Eighty percent of the adult population experiences
a significant episode of disabling low back pain over
their life. Most people recover, however, 10 to 15% go
on to develop chronic low back pain (CLBP), defined as
pain lasting over 12 weeks.4 Ninety percent of people
with CLBP have a non-specific problem with no clearly
identifiable cause for their pain.5 CLBP is increasing in
prevalence and is globally the second most frequent rea-
son for time off work.1,3 Total costs associated with back
pain in the United States are estimated at between $100
and $200 billion per year, one-third due to healthcare
costs, with the remainder due to lost wages and lower
productivity.6 It is a complex condition associated with
psychological comorbidities, such as sleep disorders, anxi-
ety, and depression.7 CLBP is often ineffectively man-
aged5 and thus debilitating for patients, challenging for
healthcare providers, and costly for society.1,2
Many people with CLBP are referred for physical therapy
but within the range of treatments used by physical thera-
pists, there is little consensus about which are the most
effective and cost effective.8 Trials have shown only modest
improvements in pain and disability following usual physi-
cal therapy treatment.9 Self-management programs can be
effective for people with CLBP10 and individualized treat-
ment may facilitate better self-care.8 Recent guidelines pro-
mote a combined psychological/physical approach if
previous treatments have proved ineffective or where there
is a medium to high risk of chronicity.8,11 Psychologically
informed practice is proposed as a middle way, integrating
traditional biomechanical and impairment-focused practice
with cognitive behavioral approaches.12 Interest in this
approach is growing, however, many questions remain,
such as how much treatment is required and whether it
can be delivered with adequate fidelity.13 Physical thera-
pists frequently report a lack of confidence in using psycho-
logical techniques successfully14 and may have difficulty
identifying psychological factors associated with CLBP.15
Recent reviews have concluded that this could be rectified
with additional training and support.16 Other findings
have suggested patients with CLBPwant to discuss personal
issues with their physical therapist,17 although many physi-
cal therapists perceive they lack the skills or confidence to
address these concerns.14 This highlights the need to
develop psychologically informed interventions that are
suitable for physical therapists and the training to help
them provide it.
Cognitive behavioral therapy (CBT) is an effective inter-
vention for CLBP18 although it remains challenging to
implement approaches to physical therapy that are based
on CBT.19 Acceptance and commitment therapy (ACT), a
newer third wave CBT, has a good evidence base in the
treatment of chronic pain3,20 but its underlying principles
of psychological flexibility have not been applied to
physical therapy. ACT focuses on improving functioning,
rather than reducing pain, using acceptance, mindfulness
strategies, and values-based action.21,22 This approach is
particularly suitable for CLBP, as a focus on symptom
reduction is frequently counter-productive.23 A trial of
ACT for CLBP delivered by psychologists found patients
2 The Journal of Painreferred for physical therapy were somewhat resistant to
seeing a psychologist and consequently recommended
combining ACT with physical therapy.24 A mixed method
study reported challenges and opportunities to embed-
ding ACT within pain rehabilitations settings that include
physical therapists.25 We have developed a brief physical
therapist-delivered intervention, theoretically under-
pinned by ACT, called PACT (physical therapy informed
by ACT).26 The main objective of this trial was to evaluate
the efficacy of PACT on functioning at the primary end
point of 3 months’ follow-up, compared with standard,
usual care (UC) physical therapy.Methods
Study Design and Participants
A phase II, assessor blind, 2-armed, parallel group,
multicenter randomized controlled trial compared the
efficacy of PACT with UC physical therapy treatment for
patients with CLBP. Participants were recruited from sec-
ondary care physical therapy clinics in 3 UK NHS (Public)
Hospital trusts in London UK (Guy’s, St Thomas’, and
Kings College Hospitals) and 1 in suburban/rural south
east England (Ashford and St Peter’s Hospital). The trial
received full Research Ethics Committee (REC) approval
(National Research Ethics Committee South Central -
Berkshire; 14/SC/0277) and conformed to current guide-
lines for ethical research. The trial was registered pro-
spectively: ISRCTN95392287.Participants
Eligible patients were adults (aged ≥18 years), with
nonspecific CLBP with or without associated leg pain, of
greater than 12 weeks’ duration, and reporting a score of
≥3 points on the Roland Morris Disability Questionnaire
(RMDQ).27 Potential participants required a good under-
standing of spoken and written English to complete trial
data collection and participate in the PACT program. Peo-
ple who had prior treatment from multidisciplinary CBT
pain management at any time and/or other physical ther-
apy treatment in the previous 6 months, or injection ther-
apy within the last 3 months, were excluded. People with
specific spinal pathology were excluded, as were people
with severe psychiatric illness and/or current drug or alco-
hol misuse, as these issues require different treatment pri-
orities. Potential participants referred to outpatient
physical therapy were identified over an 18-month period
by physical therapists from each hospital center at their
triage sessions. They were provided with written and ver-
bal information about the PACT trial and invited to par-
ticipate. Interested participants were then contacted by
the research associate to screen for eligibility. All partici-
pants gave written informed consent before taking part.Randomization and Masking
Participants were randomized to receive either PACT or
UC physical therapy. Random allocation to the 2 groups
employed random block sizes stratified by recruiting
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St Peter’s Hospitals); implemented via the King’s College
London Clinical Trials Unit online system, with emails
generated automatically and sent to relevant physical
therapy staff at study sites. Face-to-face treatment meant
it was not possible to blind participants or the physical
therapists delivering the interventions. However, the
research associate conducting outcome assessment and
the trial statistician analyzing the data were blinded to
group allocation. No hypothesis was proposed to partici-
pants about the superiority of either treatment and sepa-
rate groups of clinicians delivered PACT and UC physical
therapy to avoid contamination.Procedures
PACT was a brief physical therapy intervention,
guided by principles of ACT, designed to promote self-
management. PACT consisted of 3 individual treatment
sessions as follows: two 60-minute face-to-face sessions
2 weeks apart conducted in a private room, plus one
20-minute telephone call 1 month later. Treatment
included an initial physical assessment with feedback,
identification of value-based goals, individualized phys-
ical exercise prescription, addressing barriers and facili-
tators to self-management, and skills training to
promote psychological flexibility. It excluded manual
therapy. Total contact time was designed to be similar
to the average amount of time patients with CLBP
receive as part of UC physical therapy treatment, as
reported in UK RCTs for CLBP where UC physical therapy
was used as the control arm.28 The aim was to maximize
the potential for a treatment effect within a timeframe
that was similar to the contact received, on average, in
standard physical therapy, as this was considered a feasi-
ble way to ensure eventual implementation and cost
effectiveness. However, PACT altered the context, con-
tent and duration of physical therapy treatment, so that
it was delivered in fewer but longer sessions compared
to usual care in the UK. Further details of PACT treat-
ment are reported in the protocol paper.26
Eight experienced (Band 6 and 7) physical therapists
received a bespoke training package, including a manual
and 2-day face-to-face training program, followed by on-
going monthly group supervision from a clinical/health
psychologist and a physical therapist. Differences in
boundaries between psychologists and physical thera-
pists were carefully communicated during training, as
this was not designed to alter these boundaries. A
patient manual individualized to patient needs was pro-
vided during the first session. UC physical therapy was
provided by physical therapists (Bands 5−8) employed in
the Public Hospitals and comprised any treatment consid-
ered suitable by the treating physical therapist, including
individual physical therapy and/or back rehabilitation
classes, dynamic control classes, manual therapy, and
hydrotherapy. All PACT sessions were audio recorded to
check treatment fidelity. Attendance at UC sessions was
documented to record volume (duration and frequency)
and components (1:1, class) of UC physical therapy by
clinicians. All treatment in the trial took place in thephysical therapy clinics based at the participating hospi-
tals. Training the physical therapists effectively in PACT
treatment was an integral part of the study. To assess
fidelity, a randomly selected sample of 20% of the audio-
recorded PACT sessions was rated by 2 trained, indepen-
dent assessors. The randomization was stratified by ses-
sion (initial face-to-face, 2-week face-to-face, 1-month
telephone call) and physical therapist to ensure at least
1 session per physical therapist was assessed.Outcomes
Self-reported questionnaires were completed by
patients at baseline, 3 (primary end point) and
12 months, either online or via postal questionnaires, to
avoid any influence of the study team on the responses.
The primary outcome was patient-reported functioning
at 3 months, assessed with the RMDQ.29 The RMDQ is
a widely used well-validated measure with good reli-
ability, where a 2- to 3-point change from baseline is
considered clinically meaningful.27 Demographic data
collected at baseline included: age, gender, ethnicity,
marital and work status, and educational attainment.
Secondary outcomes included all core domains recom-
mended in chronic pain research (IMMPACT recommen-
dations).30 Secondary outcome measures were: the
Patient Health Questionnaire-9 (PHQ-9),31 to assess
depression; the Generalized Anxiety Disorder-7 (GAD-
7),32 to assess anxiety; the Patient-Specific Functional
Scale (PSFS)33 and Work and Social Adjustment Scale
(WSAS)34 to assess functioning; a life satisfaction scale;
and a pain numeric analogue scale to assess pain sever-
ity. Global Improvement,35 Outcome Satisfaction,36 and
Treatment Credibility37 questionnaires were completed
at both follow-ups. Process measures were chosen with
the intention to stay theoretically clear without redun-
dancy, as well as the need to maintain reasonable par-
ticipant burden from the assessment. Process variables
included the Chronic Pain Acceptance Questionnaire-8
(CPAQ-8)38; and Committed Action Questionnaire-8
(CAQ-8)39; as well as the Pain self-efficacy Questionnaire
(PSEQ).40 Nested qualitative studies were completed
with 20 PACT patients and all PACT physical therapists
(reported elsewhere). In addition, proposed therapeutic
mechanisms of action (process variables)38,39 were
assessed. Three bespoke treatment fidelity measures,
1 for each PACT session, were developed to appraise
physical therapists’ adherence to the PACT intervention.
A cost-consequences estimation of the economic impact
of the interventions on CLBP was completed using
patient data from 2 health-related quality of life
measures, the EQ-5D-5L,41 and MOS Short Form-12v2
(SF-12)42 Questionnaires. Serious adverse events were
reviewed by the chief investigator and reported to an
independent trial steering committee for consideration.Patient Involvement
The PACT study was developed with contributions
from 4 dedicated patient representatives, who were
recruited from local physical therapy services and
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ity study. Their contributions included the development of
PACT treatment components and materials to determine
appropriateness of content, language and format; feed-
back on key documents, such as patient information
sheets and consent forms; piloting of assessments, includ-
ing questionnaire content and delivery via an online ques-
tionnaire database, to determine acceptability, length of
surveys and estimated completion time, and resonance of
items within surveys to check relevance and acceptability.
One patient was a coapplicant on the grant funding the
trial and 2 patients were patient and public involvement
representatives on the Trial Steering Committee to ensure
it addressed issues relevant to service users.Sample Size
The trial was designed to detect a standardized mean
difference of .4 in the primary outcome (RMDQ; 5% sig-
nificance, 80% power) assuming attrition of 20%. This
difference equates to a 3-point difference between
groups (assuming the standard deviation of the RMDQ
is 7.4, as suggested by our small feasibility study and
previous research in a similar population43 where a 2- to
3-point difference in the RMDQ score is considered clini-
cally important.27 We calculated that in total 240 partici-
pants needed to be randomized.Statistical Analysis
Data were analyzed using Stata version 14.1 statistical
software. Estimates of treatment effect at the 3-month
and 12 months’ follow-up followed the intention-to-
treat principle. Between-group differences (treatment
effect) were estimated for the primary outcome (RMDQ)
at the postintervention assessments. Estimates of treat-
ment effect at the 3- and 12 months’ postrandomization
follow-up assessments were based on adjusted mean dif-
ferences using linear-mixed models following the inten-
tion-to-treat principle.44 A 3-level model was estimated
including random effects for the patient to account for
repeated assessment over time and a random effect for
physical therapist to account for partial-clustering of
patients by physical therapist in the PACT arm. Covariates
in the model included an indicator variable for group
assignment, an indicator for follow-up time, an interac-
tion term for group by time, the baseline level of the out-
come variable and indicator variables for center, as this
was a stratification factor in the randomization. Residual
diagnostics indicated heteroscedasticity for RMDQ. Stan-
dard errors that are robust to violations of the normality
and homoscedasticity assumption were estimated by
bootstrapping with 1,000 replications. Treatment effects
were converted into standardized mean differences as
Cohen’s d to allow comparison of effect sizes across out-
comes. Costs associated with delivering PACT and UC
were estimated using a combination of actual resource
used, derived from logs kept by the physical therapists
and NHS Executive reference costs for 2015/16.Results
Participant Characteristics
Between November 2014 and March 2016, 660
patients were informed about the study by their physi-
cal therapist and 478 (72%) agreed to be screened for
eligibility. Two hundred forty-eight (518%) met eligi-
bility criteria and consented to participate and so were
randomized to receive either PACT (n = 124) or UC physi-
cal therapy (n = 124). Of 124 people randomized to
PACT, 17 (14%) received no treatment and 4 (3%) had
UC physical therapy. Of 124 randomized to UC physical
therapy, 30 (24%) received no treatment and 2 (16%)
patients had PACT. Administrative delay and some con-
fusion about attending appointments that had already
been allocated led to a few people inadvertently receiv-
ing the wrong treatment. Overall, 204 patients (83%)
completed follow-up assessments at 3 months and 181
(73%) at 12 months. In total, 219 patients (88.3%) pro-
vided data on at least 1 follow-up occasion and were
retained for the intention-to-treat analysis, irrespective
of whether they received treatment. Of those receiving
PACT, 23 had 1 face-to-face session, 14 had 2 face-to-
face sessions, and 66 received both face-to-face sessions
plus the telephone session. Overall, 103 patients (83%)
completed at least 1 session of PACT. Of those allocated
to UC physical therapy, 92 (74%) received UC treatment
and they all had at least 1 face-to-face session with a
physical therapist, with the majority referred to some
form of group-based intervention after this (eg, back
rehabilitation or hydrotherapy classes). On average, par-
ticipants in UC attended 3 hours of physical therapy (eg,
three 30 minutes 1:1 sessions and one and a half 60-min-
ute classes), compared to 2 hours treatment in PACT.
There were no patients who were withdrawn or opted
to withdraw from the trial. Patient flow through the
study is presented in Fig. 1.
Baseline demographic and clinical characteristics by
treatment group are presented in Tables 1 and 2. Fifty-
nine percent of participants were female, 59% described
their ethnicity as white, and participants’ average age
was 48 years. Our participants had RMDQ mean scores
that are typical of people with CLBP seeking physical
therapy.43 Patients in our sample were in the mid-range
of pain intensity scores and many were experiencing
mild depression and anxiety symptoms, but these were
below the level where treatment should be considered.
There was good variability across the range of scores at
baseline, with sound balance across the groups achieved
by randomization. At the baseline assessment, 8 individu-
als in the PACT arm and 6 patients in the UC arm had a
RMDQ score <3 (although they had scored ≥3 during
screening and so were eligible). Of these, 6 patients in
the PACT arm and 3 patients in the UC arm were retained
in the intention-to-treat analysis as they provided data.Primary Outcome
Twenty-nine patients provided no postbaseline data
and so were not included in the analysis sample. We
Figure 1. Consort Flow diagram.
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whether excluding these patients impacted on the
results. There was a trend for those who were not
retained for the intention-to-treat analysis or not com-
pleting 12 months’ follow-up to be younger, male,
unmarried, have less education, and to report worse
health at baseline. However, only the difference in age
for those completing the 12 months’ follow-up was sta-
tistically significant, with younger patients more likely
to be lost to follow-up.
Fig. 2 shows the treatment effects based on the inten-
tion to treat sample. The mean reduction in RMDQ score
from baseline to 3 months in the PACT group was 3.4,
compared to 2.1 in the UC group (Table 3, Supplemen-
tary Materials), where a change of 2 to 3 units in theRMDQ is considered clinically meaningful.27 The inten-
tion-to-treat adjusted mean difference between groups
indicated people who received PACT reported signifi-
cantly better functioning (RMDQ) at the primary end
point of 3 months than those receiving UC (mean differ-
ence =1.07, P = .037, 95% CI =2.08 to 007, d = .2).
Clinically important reductions in RMDQ levels were
maintained at 12 months in the PACT group, although
the intention-to-treat adjusted mean difference com-
pared to UC was reduced and nonsignificant (mean dif-
ference .38, P = .52, 95% CI =1.54 to .78, d = .1).
Sensitivity analysis with the per-protocol sample (only
included those meeting the inclusion criteria at base-
line, ie, RMDQ ≥3 and receiving at least 1 session of
PACT or UC) and using baseline observation carried
Table 1. Baseline Continuous Demographic and Clinical Characteristics by Treatment Group, Ran-
domized Sample
USUAL CARE
(N = 124)
PACT
(N = 124)
TOTAL
(N = 248)
N MEAN SD N MEAN SD N MEAN SD
Age 124 47.5 14.0 124 48.4 14.6 248 47.9 14.3
BMI 112 29.1 5.2 113 28.6 5.9 225 28.9 5.6
RMDQ*,27 124 10.8 5.8 124 10.7 5.7 248 10.7 5.7
Pain 123 6.1 1.9 123 6.1 2.1 246 6.1 2.0
PSFS33 122 4.7 2.3 120 4.6 2.3 242 4.7 2.3
WSAS34 124 16.7 9.3 124 17.2 9.5 248 16.9 9.4
Life satisfaction 122 5.9 2.6 120 5.8 2.6 242 5.9 2.6
PHQ931 124 7.4 5.7 124 7.6 6.2 248 7.5 5.9
GAD732 124 6.6 5.6 124 6.3 5.5 248 6.4 5.5
CPAQ38 123 24.3 8.6 124 25.3 8.3 247 24.8 8.5
CAQ34 123 32.3 8.8 124 30.6 8.7 247 31.5 8.8
PSEQ40 123 36.5 13.5 124 37.6 14.7 247 37.1 14.1
SF12 physical42 123 37.3 7.9 122 38.3 8.7 245 37.8 8.3
SF12 mental42 123 46.8 10.6 122 46.1 10.5 245 46.5 10.6
BMI, body mass index.
*Measures reference numbers in superscript.
Table 2. Baseline Categorical Demographic and Clinical Characteristics by Treatment Group, Ran-
domized Sample
USUAL CARE
(N = 124)
PACT
(N = 124)
TOTAL
N = 248
N % N % N %
Gender Male 53 42.7 48 38.7 101 40.7
Female 71 57.3 76 61.3 147 59.3
Total 124 100.0 124 100.0 248 100.0
Ethnicity White 74 59.7 72 58.1 146 58.9
Mixed 7 5.6 7 5.6 14 5.6
Asian 9 7.3 10 8.1 19 7.7
Black 32 25.8 31 25.0 63 25.4
Other/unknown 2 1.6 4 3.2 6 2.4
Total 124 100.0 124 100.0 248 100.0
Marital status Unmarried 35 28.5 32 26.0 67 27.2
Married/partner 64 52.0 63 51.2 127 51.6
Separated/divorced/widowed 24 19.5 28 22.8 52 21.1
Total 123 100.0 123 100.0 246 100.0
Education No qualifications 17 13.8 24 19.7 41 16.7
High school diploma equivalent 34 27.6 36 29.5 70 28.6
AP equivalent 27 22.0 24 19.7 51 20.8
Degree/equivalent 45 36.6 38 31.1 83 33.9
Total 123 100.0 122 100.0 245 100.0
Work status Employed F/T 59 48.4 50 41.3 109 44.9
Employed P/T 28 23.0 31 25.6 59 24.3
Unemployed 17 13.9 17 14.0 34 14.0
Retired 18 14.8 23 19.0 41 16.9
Total 122 100.0 121 100.0 243 100.0
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confirmed the robustness of the intention-to-treat estimate
with estimates of the treatment effect of 1.43 (P= .008)
and .85 (P= .041), respectively (Table 4, Supplementary
Materials).Secondary Outcomes and Process
Variables
Participants who received PACT rated their treatment as
more credible compared then those receiving UC physical
Figure 2. Standardized treatment effect sizes with 95% confidence intervals.
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outcome on the Patient-Specific Functional Scale, SF-12
physical health scale and Work and Social Adjustment
Scale at 3, but not 12 months (supplementary Materials).
No group differences were observed for measures of pain,
mood, self-efficacy, or the ACT process variables (accep-
tance [CPAQ-8] and committed action [CAQ-8]) at 3 or 12
months. Twenty-one trial participants reported adverse
events, 9 from PACT and 12 from UC. The Trial Steering
Committee concluded that no adverse events reported by
patients were related to treatment.Fidelity
Eight physical therapists delivered PACT (mean age
33, range = 24−44 years; 5 female). Bespoke fidelity
measures were developed for this trial, including all the
elements of treatment that were expected to be deliv-
ered in each session. Seventy-two (20%) audio tapes
were rated by independent assessors. Prior to the cali-
bration of scores, overall agreement between raters was
85% (474/560 decisions; 95% CI = 81−88%), when rating
whether treatment elements were fully completed, par-
tially completed, or not completed. Treatment fidelity
was calculated according to whether a minimum of
80% of treatment elements were rated as being com-
pleted/partially completed by the physical therapist,
from calibrated total scores for each individual session.
The results confirmed physical therapist adherence to
the PACT intervention was high,45 with overall 88%
(95% CI = 78−94%) treatment fidelity achieved across
sessions (session 1: 97%, 95% CI = 84−100%; session 2:
81%, 95% CI = 62−94%; session 3: 77%, 95% CI = 46
−95%). Fidelity assessment also revealed that only a few
core ACT methods were delivered overall, with average
ACT fidelity across all 72 sessions scored as 16.4 out of40. This was as expected after only 2 days’ training in
this ACT informed physical therapy treatment.Cost Consequences
The cost-consequences analysis revealed the total
CLBP-associated costs in the PACT arm were £19,776, or
£193.88 per patient, compared to £20,286 or £220.50
per patient, in the UC physical therapy arm. However,
PACT had additional one-off training costs of £11,958.
UK NHS (public health service) resource use across the
3-time points was very comparable between the 2
groups. Over the 12-month follow-up period, resource
utilization was similar between groups, with direct NHS
healthcare costs accounting for 25% (£151,345.77/
£595,821.07) of total costs, while 13% (£77,673.00) was
attributable to private costs paid for by the patient and
62% (£366,802.30) to societal costs, such as time off
work. Direct NHS healthcare costs reduced in both
groups over time and were £98.79 per person cheaper
at 12 months’ follow-up in UC and £104.63 cheaper per
person in PACT. Costs associated with absenteeism fell
from £597.25 to £223.63 per person in UC and from
£447.72 to £244.43 per person in PACT.Discussion
This is the first trial to test the efficacy of an ACT-
informed physical therapist-delivered intervention for
people with CLBP. PACT significantly improved partic-
ipants’ back pain disability at the primary end point of
3 months’ follow-up compared to UC physical therapy,
although effect sizes were small and not sustained at
12 months. PACT participants achieved a clinically mean-
ingful reduction of over 3 points on the RMDQ at both 3
and 12 months compared to baseline levels; UC also
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3 months and 12 months, where 2 to 3 points are gener-
ally judged to be clinically important.27 PACT participants
showed significantly greater improvements in secondary
measures of pain-related interference at 3 but not
12 months. People who received PACT rated their treat-
ment as having greater credibility. The cost-consequences
analysis revealed no major cost differences between PACT
and UC (with PACT training costs excluded, as this type of
brief training could be incorporated into continuing pro-
fessional development) and that resource use reduced
over time in both groups, which could reflect improve-
ments due to treatment or simply the natural history of
the condition. PACT had lower attrition and total treat-
ment was completed within a mean of 2 hours, in contrast
to 3 hours for UC. No between-group differences were
observed on the remaining secondary outcomes including
pain, mood, self-efficacy, or the ACT process variables
(acceptance and committed action). PACT was designed
to shift the focus from pain to daily functioning and as
reducing pain was not the primary aim of treatment, it
was not surprising that there was no difference between
groups. Depression and anxiety scores in the PACT trial
were below clinical cut-offs at baseline and were mini-
mally targeted as part of treatment, which could explain
the lack of change in these measures.
Previous research established ACT was effective for
treating chronic pain,20,46 with small to medium effects
on functioning and disability and suggested combining it
with physical therapy might make it more acceptable to
patients with CLBP referred to that service.24 Our results
support these findings and are in line with a recent meta-
analysis of CBT for non-specific low back pain, which
found the effect of CBT versus other recommended active
treatments ranged from small to moderate; and that
most studies maintained a clinically meaningful 30%
decrease in the RMDQ over the long term.18
Recruitment and retention data suggest the trial was
well designed and implemented and that PACT was an
acceptable treatment approach for patients with CLBP
referred to physical therapy. Of the 660 patients
informed about the study by their physical therapist,
72% (478) were screened and 248 (51.8%) met selection
criteria and agreed to participate. Retention in the trial
was excellent, with 219 (88.3%) providing follow-up
data. These findings are supported by our nested quali-
tative study of 20 PACT participants, which also indi-
cated treatment was acceptable to participants. This is
essential as treatment expectancy and credibility have
been shown to be associated with better outcome in
physical and CBT treatments of patients with CLBP.47
The PACT treatment approach also has potential to
address physical therapists’ barriers to using psychological
techniques effectively.25 Recent research has highlighted
some of the complexity in psychologically informed treat-
ment,13 such as treatment specification, cost, and inter-
vention fidelity, which we have explored in this trial. In
addition, systematic reviews have concluded that physical
therapists’ lack of confidence in successfully delivering psy-
chological interventions might be rectifiedwith additional
training and support.16,19 We have demonstrated thatACT-related skills could be successfully integrated into
usual physical therapy with additional staff training and
support. Our 2-day training and on-going monthly super-
vision seem to have provided suitable support, enabling
physical therapists to deliver PACT with high fidelity. Feed-
back within training sessions indicated that none of the
methods trained deviated substantially from what the
physical therapists would consider within their scope of
practice. This is imperative because higher levels of treat-
ment fidelity are associated with better retention rates
and treatment outcomes.45 Our nested qualitative study
of PACT physical therapist found treatment was accept-
able and feasible. These findings suggest PACT could suc-
cessfully broaden physical therapists’ scope of practice
when treating patients with CLBP. However, our results
suggest structural barriers, like the availability of private
rooms and supervision/support, need to be addressed for
physical therapists to incorporate psychological techni-
ques successfully.
Both groups in the trial were comparable at baseline
demonstrating randomization worked well and both
received physical therapy, with separate groups of clini-
cians delivering the treatments, which limits bias and
strengthens the validity of results. However, there were
some sources of bias that need to be considered. Some
aspects of the trial were more pragmatic than explanatory
(see PRECIS figure in Supplementary Materials) and as a
result, a higher percentage of UC participants received no
treatment. However, the rate of non-attendance was simi-
lar to previous reports from UK physical therapy trials in
this population.43 A weakness of the study was our inabil-
ity to collect accurate information on the number and
type of care providers in the UC arm or comparable data
on the UC sessions patients attended. In addition, as most
participants who were lost to follow-up did not return
questionnaires, we were not able to collect the reasons
why they were lost to follow-up. The PACT trial restricted
eligibility to participants speaking good English, referred
to physical therapy in public hospitals in London and
South East England and excluded those with severe psychi-
atric comorbidities common in chronic pain, which some-
what limits generalizability.
PACT was not designed to turn physical therapists into
ACT practitioners and, as expected, the fidelity assess-
ment showed that few ACT-consistent methods were
delivered. Moreover, the theory-derived measures, used
to assess acceptance and committed action, indicated
no differences between groups. This means the mecha-
nisms of action behind the improvement in disability
with PACT are unclear and suggests the treatment needs
some redesign and/or the training could be enhanced,
to ensure PACT is delivered with higher competency
and with greater impact on these key processes.48 More
research is required to refine the PACT intervention,
enhance efficacy, and maintain effects over the longer
term. It would be valuable to explore how to optimize
impact on the specific intended processes of change,
namely acceptance and committed action, as an impor-
tant question persist about how to facilitate this with
clear implications for wider delivery and training. Fur-
thermore, in terms of mechanisms of action, it is
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more psychological model of treatment delivery (longer
sessions, private rooms, and on-going therapist supervi-
sion) from the specific content of sessions. In future
research, we intended to further investigate training,
fidelity, and competency questions. There may also
have been some contamination in UC, as CBT-based
methods are sometimes employed within routine physi-
cal therapy.15,19 It is possible that PACT treatment was
too brief, as it involved 1 hour less treatment than UC,
and increasing the dose with additional sessions might
help maintain benefits. Additional training and support
materials might address these issues and could increase
access to PACT. In addition, it might be fruitful to inves-
tigate if the advantages of PACT over UC are clearer in
patients with greater disability or more psychosocial risk
factors at baseline.
The findings from the PACT trial are encouraging and
have the potential to improve the management of peo-
ple with CLBP. The PACT treatment approach can
address physical therapists’ barriers to using psychologi-
cal techniques,25 as well as patients’ concerns about
finding a credible treatment offering aspects of care
they value.17 As physical therapy is a common treatment
for CLBP and millions of patients are referred to physical
therapists every year, even small additional benefits
could have a considerable impact for patients, health-
care providers, and society. Next steps might include
refining the training and support for physical therapists,
as well as investigating whether to select patients and/
or provide additional treatment sessions. Further
booster sessions should be considered and could be
delivered remotely, as in other musculoskeletal condi-
tions, to help maintain the effects of treatment over
time. More research is warranted to develop successful
care in the long term and to determine whether PACT is
effective and cost effective in a larger trial.Ethics Committee Approval
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